69193-39-1 → HCID 54335788, 화합물

HRID 1432974노트

반응식

HRID 1432974 반응식
[NH2:1][C:2]1[C:11]2[C:6](=[CH:7][C:8]([CH2:12][N:13]3[CH2:18][CH2:17][NH:16][CH:15]([CH2:19][CH3:20])[C:14]3=[O:21])=[CH:9][CH:10]=2)[N:5]=[CH:4][N:3]=1.[Cl:22][C:23]1[S:27][C:26](/[CH:28]=[CH:29]/[C:30](O)=[O:31])=[CH:25][CH:24]=1>>[NH2:1][C:2]1[C:11]2[C:6](=[CH:7][C:8]([CH2:12][N:13]3[CH2:18][CH2:17][N:16]([C:30](=[O:31])[CH:29]=[CH:28][C:26]4[S:27][C:23]([Cl:22])=[CH:24][CH:25]=4)[C@@H:15]([CH2:19][CH3:20])[C:14]3=[O:21])=[CH:9][CH:10]=2)[N:5]=[CH:4][N:3]=1

참가 물질

3

반응물 2

HCID 1310045069193-39-1HCID 179851971-(4-Aminoquinazoline-7-ylmethyl)-3-ethylpiperazine-2-one

생성물 1

HCID 54335788HCID 54335788, 화합물

실험 절차

The title compound is prepared as described in EXAMPLE 123, using 1-(4-aminoquinazoline-7-ylmethyl)-3-ethyl-piperazine-2-one, EXAMPLE 77 and 3-(5-chloro-thiophen-2-yl)-(E)-acrylic acid, EXAMPLE 25. 1H NMR(d6-DMSO+1 drop TFA, 300 MHz) δ9.78 (bs, 2H), 8.79 (s, 1H), 8.37 (d, 1H), 7.65 (m, 2H), 7.50 (s, 1H), 7.41 (m, 1H), 7.11 (d, 1H), 6.98 (d, 1H), 4.88 (m, 2H), 4.60 (m, 1H), 4.31 (m, 1H), 3.52 (m, 1H), 3.30 (m, 2H), 1.96 (m, 2H), 0.88 (m, 3H). MS (ion spray), m/z, (M+H)=456, 458 (Cl pattern). Elemental analysis, cal C22H22ClN5O2S.1.5C2HF3O2% C=47.89, % H=3.78, % N=11.17; found % C=47.34, % H=4.00, % N=11.12.

출처 및 근거

ORD 기록
ord-173988e2e8b84edc83137ba5890d8a3a
출처 데이터셋
uspto-grants-2009_11
특허 번호
US07612075B2

반응 노트

불러오는 중…